Literature DB >> 29321331

Germ Line IgM Is Sufficient, but Not Required, for Antibody-Mediated Alphavirus Clearance from the Central Nervous System.

Voraphoj Nilaratanakul1,2, Jie Chen1, Oanh Tran1, Victoria K Baxter1,2, Elizabeth M Troisi1, Jane X Yeh1, Diane E Griffin3.   

Abstract

Sindbis virus (SINV) infection of neurons in the brain and spinal cord in mice provides a model system for investigating recovery from encephalomyelitis and antibody-mediated clearance of virus from the central nervous system (CNS). To determine the roles of IgM and IgG in recovery, we compared the responses of immunoglobulin-deficient activation-induced adenosine deaminase-deficient (AID-/-), secretory IgM-deficient (sIgM-/-), and AID-/- sIgM-/- double-knockout (DKO) mice with those of wild-type (WT) C57BL/6 mice for disease, clearance of infectious virus and viral RNA from brain and spinal cord, antibody responses, and B cell infiltration into the CNS. Because AID is essential for immunoglobulin class switch recombination and somatic hypermutation, AID-/- mice produce only germ line IgM, while sIgM-/- mice secrete IgG but no IgM and DKO mice produce no secreted immunoglobulin. After intracerebral infection with the TE strain of SINV, most mice recovered. Development of neurologic disease occurred slightly later in sIgM-/- mice, but disease severity, weight loss, and survival were similar between the groups. AID-/- mice produced high levels of SINV-specific IgM, while sIgM-/- mice produced no IgM and high levels of IgG2a compared to WT mice. All mice cleared infectious virus from the spinal cord, but DKO mice failed to clear infectious virus from brain and had higher levels of viral RNA in the CNS late after infection. The numbers of infected cells and the amount of cell death in brain were comparable. We conclude that antibody is required and that either germ line IgM or IgG is sufficient for clearance of virus from the CNS.IMPORTANCE Mosquito-borne alphaviruses that infect neurons can cause fatal encephalomyelitis. Recovery requires a mechanism for the immune system to clear virus from infected neurons without harming the infected cells. Antiviral antibody has previously been shown to be a noncytolytic means for alphavirus clearance. Antibody-secreting cells enter the nervous system after infection and produce antiviral IgM before IgG. Clinical studies of human viral encephalomyelitis suggest that prompt production of IgM is associated with recovery, but it was not known whether IgM is effective for clearance. Our studies used mice deficient in production of IgM, IgG, or both to characterize the antibody necessary for alphavirus clearance. All mice developed similar signs of neurologic disease and recovered from infection. Antibody was necessary for virus clearance from the brain, and either early germ line IgM or IgG was sufficient. These studies support the clinical observation that prompt production of antiviral antibody is a determinant of outcome.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Sindbis virus; antibody; mice; neurons; viral encephalomyelitis; virus clearance

Mesh:

Substances:

Year:  2018        PMID: 29321331      PMCID: PMC5972861          DOI: 10.1128/JVI.02081-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Alphavirus-induced encephalomyelitis: antibody-secreting cells and viral clearance from the nervous system.

Authors:  Talibah U Metcalf; Diane E Griffin
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

2.  Protective Effects of Glutamine Antagonist 6-Diazo-5-Oxo-l-Norleucine in Mice with Alphavirus Encephalomyelitis.

Authors:  Sivabalan Manivannan; Victoria K Baxter; Kimberly L W Schultz; Barbara S Slusher; Diane E Griffin
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

3.  Synergistic roles of antibody and interferon in noncytolytic clearance of Sindbis virus from different regions of the central nervous system.

Authors:  Rebeca Burdeinick-Kerr; Jennifer Wind; Diane E Griffin
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

4.  Gamma interferon-dependent, noncytolytic clearance of sindbis virus infection from neurons in vitro.

Authors:  Rebeca Burdeinick-Kerr; Diane E Griffin
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

5.  Fatal outcome in Japanese encephalitis.

Authors:  D S Burke; W Lorsomrudee; C J Leake; C H Hoke; A Nisalak; V Chongswasdi; T Laorakpongse
Journal:  Am J Trop Med Hyg       Date:  1985-11       Impact factor: 2.345

6.  Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells.

Authors:  M Muramatsu; V S Sankaranand; S Anant; M Sugai; K Kinoshita; N O Davidson; T Honjo
Journal:  J Biol Chem       Date:  1999-06-25       Impact factor: 5.157

7.  A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene.

Authors:  D Kitamura; J Roes; R Kühn; K Rajewsky
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

8.  Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2).

Authors:  P Revy; T Muto; Y Levy; F Geissmann; A Plebani; O Sanal; N Catalan; M Forveille; R Dufourcq-Labelouse; A Gennery; I Tezcan; F Ersoy; H Kayserili; A G Ugazio; N Brousse; M Muramatsu; L D Notarangelo; K Kinoshita; T Honjo; A Fischer; A Durandy
Journal:  Cell       Date:  2000-09-01       Impact factor: 41.582

9.  Unmutated immunoglobulin M can protect mice from death by influenza virus infection.

Authors:  Yuichi Harada; Masamichi Muramatsu; Toshikatsu Shibata; Tasuku Honjo; Kazumichi Kuroda
Journal:  J Exp Med       Date:  2003-06-09       Impact factor: 14.307

10.  Identity of the elusive IgM Fc receptor (FcmuR) in humans.

Authors:  Hiromi Kubagawa; Satoshi Oka; Yoshiki Kubagawa; Ikuko Torii; Eiji Takayama; Dong-Won Kang; G Larry Gartland; Luigi F Bertoli; Hiromi Mori; Hiroyuki Takatsu; Toshio Kitamura; Hiroshi Ohno; Ji-Yang Wang
Journal:  J Exp Med       Date:  2009-10-26       Impact factor: 14.307

View more
  9 in total

1.  Immunopathogenesis of alphaviruses.

Authors:  Victoria K Baxter; Mark T Heise
Journal:  Adv Virus Res       Date:  2020-07-08       Impact factor: 9.937

2.  Why does viral RNA sometimes persist after recovery from acute infections?

Authors:  Diane E Griffin
Journal:  PLoS Biol       Date:  2022-06-01       Impact factor: 9.593

Review 3.  Insights into Antibody-Mediated Alphavirus Immunity and Vaccine Development Landscape.

Authors:  Anthony Torres-Ruesta; Rhonda Sin-Ling Chee; Lisa F P Ng
Journal:  Microorganisms       Date:  2021-04-22

Review 4.  Genetic control of alphavirus pathogenesis.

Authors:  Victoria K Baxter; Mark T Heise
Journal:  Mamm Genome       Date:  2018-08-27       Impact factor: 2.957

Review 5.  Antiviral Functions of Monoclonal Antibodies against Chikungunya Virus.

Authors:  Jing Jin; Graham Simmons
Journal:  Viruses       Date:  2019-03-28       Impact factor: 5.048

6.  Maternal antibodies facilitate Amyloid-β clearance by activating Fc-receptor-Syk-mediated phagocytosis.

Authors:  Tomer Illouz; Raneen Nicola; Linoy Ben-Shushan; Ravit Madar; Arya Biragyn; Eitan Okun
Journal:  Commun Biol       Date:  2021-03-12

7.  Editorial: Immunotherapy for Tumor in the Brain: Insights From-and For-Other Tumor Sites.

Authors:  Lois A Lampson
Journal:  Front Oncol       Date:  2018-04-27       Impact factor: 6.244

8.  Both ADP-Ribosyl-Binding and Hydrolase Activities of the Alphavirus nsP3 Macrodomain Affect Neurovirulence in Mice.

Authors:  Rachy Abraham; Robert L McPherson; Morgan Dasovich; Mohsen Badiee; Anthony K L Leung; Diane E Griffin
Journal:  mBio       Date:  2020-02-11       Impact factor: 7.867

Review 9.  Acute RNA Viral Encephalomyelitis and the Role of Antibodies in the Central Nervous System.

Authors:  Maggie L Bartlett; Diane E Griffin
Journal:  Viruses       Date:  2020-09-05       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.